Article
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
British journal of cancer - 1 Feb 2022
Suppan Christoph, Graf Ricarda, Jahn Stephan, Zhou Qing, Klocker Eva Valentina, Bartsch Rupert, Terbuch Angelika, Kashofer Karl, Regitnig Peter, Lindenmann Joerg, Posch Florian, Gerritsmann Hanno, Jost Philipp J, Heitzer Ellen, Dandachi Nadia, Balic Marija
Abstract excerpt
BACKGROUND: The benefit of alpelisib in hormone-receptor-positive (HR+) metastatic breast cancer patients provided clinical evidence for the increasing importance of PIK3CA testing. We performed a comparison of liquid biopsy and tissue-based detection of PIK3CA mutations. MATERIALS AND METHODS: PIK3CA hotspot mutation analysis using a high-resolution SiMSen-Seq assay was performed in plasma from 93/99 eligible...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
